Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.56 |
| ▸ | HMGCR | P04035 | 3/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7341770 | 1.00 | PTPN7 (0.56) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL7350770 | 1.00 | PTPN7 (0.56) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL487742 | 1.00 | PTPN7 (0.56) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL9496128 | 1.00 | PTPN7 (0.56) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL23014964 | 1.00 | PTPN7 (0.56) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL15766733 | 1.00 | PTPN7 (0.56) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL23015081 | 1.00 | PTPN7 (0.56) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL1537343 | 1.00 | PTPN7 (0.56) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL1537174 | 1.00 | PTPN7 (0.56) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL1550995 | 1.00 | PTPN7 (0.56) | PTPN7HMGCRRECQLTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622891-B2 | AMP-activated protein kinase activator | KYOTO PHARMACEUTICAL UNIVERSITY (JP) | 2026-05-12 | — | — | US | disclosed |
| WO-2025077836-A1 | IONIZABLE LIPIDS AND LIPID NANOPARTICLES FOR RNA DELIVERY | BEIGENE SWITZERLAND GMBH (CH) | 2025-04-17 | — | — | WO | disclosed |
| EP-4281433-B1 | INCENSE ODORANT | FIRMENICH & CIE (CH) | 2024-12-25 | — | — | EP | disclosed |
| CN-116444464-B | Method for asymmetrically synthesizing inchworm sex pheromone | 中国农业大学 | 2024-11-22 | — | — | CN | disclosed |
| US-20240277657-A1 | NOVEL AMP-ACTIVATED PROTEIN KINASE ACTIVATOR | KYOTO PHARMACEUTICAL UNIVERSITY (JP) | 2024-08-22 | — | — | US | disclosed |
| US-20240199524-A1 | INCENSE ODORANT | FIRMENICH & CIE (CH) | 2024-06-20 | — | — | US | disclosed |
| EP-4349331-A1 | NOVEL AMP-ACTIVATED PROTEIN KINASE ACTIVATOR | Kyoto Pharmaceutical University (JP) | 2024-04-10 | — | — | EP | disclosed |
| CN-117794527-A | Novel AMP-activating protein kinase activators | 学校法人京都药科大学 | 2024-03-29 | — | — | CN | disclosed |
| US-20240050378-A1 | LIPID NANOPARTICLE COMPOSITIONS CONTAINING MONOESTER CATIONIC LIPIDS | MERCK SHARP & DOHME LLC (US) | 2024-02-15 | — | — | US | disclosed |
| EP-4281433-A1 | INCENSE ODORANT | Firmenich SA (CH) | 2023-11-29 | — | — | EP | disclosed |
| WO-2016079431-A1 | 2-OCTYLCYCLOPROPYL-1-CARBOXYLIC ACID AND THE ISOMERS THEREOF, AND USES OF SAME | ALBERT VIEILLE (FR) | 2016-05-26 | — | — | WO | disclosed |
| US-8445511-B2 | Quinoline or quinoxaline derivatives for treating neurodegenerative diseases | Centre National de la Recherche Scientifique (SNRS) (FR) | 2013-05-21 | — | — | US | disclosed |
| US-20110118270-A1 | HETEROCYCLIC DERIVATIVES THAT ARE USED IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE(CNRS) | 2011-05-19 | — | — | US | disclosed |
| EP-2313373-A1 | HETEROCYCLIC DERIVATIVES THAT ARE USED IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | Centre National de la Recherche Scientifique (C.N.R.S) (FR) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010007179-A1 | HETEROCYCLIC DERIVATIVES THAT ARE USED IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2010-01-21 | — | — | WO | disclosed |
| EP-0483851-B1 | Pyrazolyl acrylic acid derivatives, intermediates thereto, and agricultural/horticultural fungicides containing said derivatives | MITSUBISHI CHEM CORP (JP) | 1996-03-13 | — | — | EP | disclosed |
| WO-1993025521-A1 | ARYL ALIPHATIC ACIDS | BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) | 1993-12-23 | — | — | WO | disclosed |
| US-5238832-A | Lipoxygenase inhibitors | BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) | 1993-08-24 | — | — | US | disclosed |
| US-5128350-A | PYRAZOLYL ACRYLIC ACID DERIVATIVES AND AGRICULTURAL/HORTICULTURAL FUNGICIDES CONTAINING SAID DERIVATIVES | MITSUBISHI KASEI CORPORATION (JP) | 1992-07-07 | — | — | US | disclosed |
| EP-0483851-A1 | Pyrazolyl acrylic acid derivatives, intermediates thereto, and agricultural/horticultural fungicides containing said derivatives | Mitsubishi Chemical Corporation (JP) | 1992-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199524-A1 | INCENSE ODORANT | OPRM1, CPT1A, TAS2R5 | PTPN7 4844/4885HMGCR 1802/4885RECQL 3593/4885 |
| US-12622891-B2 | AMP-activated protein kinase activator | PRKAA1, PRKAG1, PRKAB1 | PTPN7 1234/4885HMGCR 3962/4885RECQL 2297/4885 |
| US-20240277657-A1 | NOVEL AMP-ACTIVATED PROTEIN KINASE ACTIVATOR | PRKAG1, PRKAG2, PRKAB1 | PTPN7 1882/4885HMGCR 4613/4885RECQL 1856/4885 |
| US-20240050378-A1 | LIPID NANOPARTICLE COMPOSITIONS CONTAINING MONOESTER CATIONIC LIPIDS | LIPA, LIPC, MGLL | PTPN7 1984/4885HMGCR 305/4885RECQL 1697/4885 |
| US-20110118270-A1 | HETEROCYCLIC DERIVATIVES THAT ARE USED IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | HCRTR2, HCRTR1, CHRNA2 | PTPN7 4301/4885HMGCR 634/4885RECQL 2509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.